WIC International Perspective: A Canadian Cardiologist Who Has Stuck to Her Roots acc.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acc.org Daily Mail and Mail on Sunday newspapers.
Article content
There’s little doubt that COVID-19 has been the top item on the news and the dominant topic of conversation for the last year from masks and lockdowns to hospital capacity and vaccines. But one of the less-discussed aspects of the pandemic is the indirect effect of the virus.
As the health-care system grapples with COVID-19, the measures taken to combat the pandemic and our own behavioural responses have had an impact on our health.
We apologize, but this video has failed to load.
Try refreshing your browser, or Opinion: Don t let COVID keep you from the family doctor or the emergency ward Back to video
Associations are a vital part of Canada’s economy.
The OTUS Association Exchange (OAX) is an annual survey and benchmarking of Canada’s associations. The objective is to provide association executives with information about how their peers and competitors approach common business problems.
In 2020, OAX focused on the top risks facing associations during the COVID-19 pandemic. In 2021, this focus has shifted toward support and recovery measures.
In collaboration with
The Write Paige Inc., OAX hosted an Association Recovery Roundtable in December 2020. We gathered virtually with five chief executive officers, selected from a cross-section of Canada’s associations, to learn about their experiences during the pandemic and hear their perspectives about recovery.
E-Mail
IMAGE: Dr. Husam Abdel-Qadir, lead author of the paper and cardiologist at the Peter Munk Cardiac Centre and Women s College Hospital. view more
Credit: Photo: UHN
Toronto - New research from UHN s Peter Munk Cardiac Centre (PMCC) shows statins, commonly prescribed to lower cholesterol and reduce the risk of heart disease and stroke, may also protect the heart from damaging side-effects of early breast cancer treatment.
Published Jan. 6, 2021 in the
Journal of the American Heart Association, an observational study found women already taking statins and treated with either anthracyclines or trastuzumab were half as likely to be hospitalized or visit an Emergency Department for heart failure within five years after chemotherapy.
E-Mail
DALLAS, Jan. 6, 2021 Statins, common cholesterol-lowering medications, may protect women s hearts from damage caused during chemotherapy for early-stage breast cancer, according to new research published today in the
Journal of the American Heart Association, an open access journal of the American Heart Association. Two types of cancer medications, anthracyclines and trastuzumab, are effective treatments for many women with breast cancer, however, the risk of heart muscle damage has limited their use, particularly in women who are at higher risk for heart problems because of their age or other medical issues, said Husam Abdel-Qadir, M.D., Ph.D., lead author of the study, assistant professor of medicine at the University of Toronto s Institute of Health Policy, Management and Evaluation, and a cardiologist at Women s College Hospital and the Peter Munk Cardiac Centre, part of the University Health Network in Toronto.